Trevi Therapeutics to Participate in Upcoming April Events
NEW HAVEN, Conn., April 4, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ for the treatment of chronic...